Aurora Cannabis (ACB.TO)

Aurora Cannabis stock price today, ATLAS forecast and fair value

Healthcare · Drug Manufacturers - Specialty & Generic · Toronto Stock Exchange · Canada

CA$5.81▲ +5.83%

Prices as of Oct 27, 2026 · CAD

ATLAS fair value

ATLAS has no fair value for this stock today.

Chance of rising in 1 month

47%

that it ends higher than today in 21 sessions

0%coin flip 50%100%

This is just the summary. See everything on Aurora Cannabis in ATLAS

ATLAS's own quantitative analysis, all in one place.

Simulation and expected rangeThousands of simulated scenarios: how far the price could rise or fall.
Officers and shareholdersWho runs the company and which funds hold its shares.
Customer and supplier mapWho it does business with, from its own filings.
ATLAS builds your portfolioAnswer a short test and get portfolios that fit you.
AlertsWe let you know when something changes in your stocks.

See everything included

Valuation and financialsFair value step by step, quarterly accounts and upcoming events.
NewsThe latest on the company, in one place.
Crisis simulatorHow your portfolio would do in a crash like 2008.
Practice risk-free$10,000 in virtual money to invest at real prices.
Global screenerSearch US stocks and stocks from 47 countries with filters.

On Aurora Cannabis

Simulation and expected rangeThousands of simulated scenarios: how far the price could rise or fall.
Officers and shareholdersWho runs the company and which funds hold its shares.
Customer and supplier mapWho it does business with, from its own filings.
Valuation and financialsFair value step by step, quarterly accounts and upcoming events.
NewsThe latest on the company, in one place.

And for you

ATLAS builds your portfolioAnswer a short test and get portfolios that fit you.
AlertsWe let you know when something changes in your stocks.
Crisis simulatorHow your portfolio would do in a crash like 2008.
Practice risk-free$10,000 in virtual money to invest at real prices.
Global screenerSearch US stocks and stocks from 47 countries with filters.

Get started →

Plans from €3.99 a month.

ATLAS's model gives Aurora Cannabis a 47% chance of finishing higher a month from now (21 trading sessions) than today: close to a coin flip.

In half of the simulated outcomes the price ends between CA$5.10 and CA$6.45; in 9 out of 10, between CA$4.14 and CA$7.94. Estimated annual volatility is 65%.

Price, last 12 months (weekly close)

Key numbers

Market cap: CA$375M
Market cap (USD): $267M
52-week high: CA$8.75
52-week low: CA$3.59
Revenue (12 months): CA$314M
Gross margin: 44.2%
Operating margin: -12.9%
Net margin: -38.3%
Beta: 1.42

What this means

ATLAS does not publish a fair value for ACB.TO right now, but it does show its odds of rising: close to a coin flip.

Over the last 52 weeks ACB.TO has traded between CA$3.59 and CA$8.75. Today it is 33.6% below that high and 62% above its low.

Its beta is 1.42: it tends to move more than the market, both up and down.

About the company

Aurora Cannabis Inc., together with its subsidiaries, engages in the production, distribution, and sale of cannabis products in Canada and internationally. The company offers pharmaceutical-grade cannabis products; and medical and consumer cannabis products.

Want to see everything about Aurora Cannabis?

Get started →

Plans from €3.99 a month.

Comparable companies

Other companies in the same line of business:

Frequently asked questions

What does Aurora Cannabis do?

What is the chance ACB.TO goes up next month?

47%: close to a coin flip. In half of the simulated outcomes, ACB.TO ends the month between CA$5.10 and CA$6.45.

How big is Aurora Cannabis and what is its P/E ratio?

Aurora Cannabis's market capitalization is CA$375M. We do not show a P/E because it has no positive earnings to base one on.

How volatile is ACB.TO?

ATLAS estimates annual volatility at 65%. In a typical month, half of the outcomes end between CA$5.10 and CA$6.45.

Not investment advice. ATLAS estimates are produced by statistical models from public data; they can be wrong and past performance does not predict future results. Consider your own situation before investing. Disclaimer